CBD Safety, Side Effects, and Drug Interactions: The Complete 2026 Reference | PureCraft CBD

This article is for informational purposes only and does not constitute medical advice. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. If you are on prescription medications or have a medical condition, consult your physician before using CBD. Zero-THC broad-spectrum; batch COA at purecraftcbd.com/pages/faq.

By the PureCraft CBD Editorial Team  |  Updated 2026  |  18 min read

CBD Safety: The Overall Picture

CBD (cannabidiol) has been evaluated in hundreds of clinical trials and reviewed by the World Health Organization, which concluded in 2018 that CBD exhibits a good safety profile with no evidence of abuse potential or public health harm. The FDA-approved pharmaceutical CBD (Epidiolex) has been extensively characterized in clinical trials at doses of 10–20mg/kg/day — substantially higher than typical OTC supplement doses of 15–50mg/day. At supplement doses, CBD's serious adverse effect risk is low, but it is not zero, and specific populations face meaningful drug interaction and contraindication risk that requires individualized assessment.

This article provides a comprehensive, evidence-referenced safety reference for CBD supplementation — covering side effects, drug interactions, population-specific guidance, and who should not use CBD without physician supervision.

Common Side Effects at Supplement Doses

The most commonly reported side effects of CBD at typical supplement doses (15–50mg/day) are mild and dose-dependent:

• Fatigue / drowsiness: The most commonly reported side effect. CBD's sedating effects are dose-dependent — at supplement doses (15–30mg), sedation is mild or absent for most people; at higher doses (50mg+), drowsiness is more likely. Timing matters: evening or bedtime dosing makes fatigue a feature rather than a side effect; morning dosing in sensitive individuals may cause unwanted drowsiness. Reduce dose or shift timing if this occurs.
• Dry mouth: CBD (and cannabinoids generally) reduces salivary secretion through CB1 receptors in submandibular glands. Generally mild; hydration addresses it.
• Diarrhea / GI upset: More common at higher doses (above 50mg) and particularly with oil-based CBD products taken on an empty stomach. The GI effect is dose-dependent and often resolves with dose reduction or taking CBD with food. In Epidiolex trials at 10–20mg/kg/day, diarrhea was the most common adverse event — at supplement doses, it is less frequent and milder.
• Changes in appetite: Both appetite increase and decrease have been reported; effect direction varies by individual and dose. Not typically clinically significant at supplement doses.
• Dizziness / lightheadedness: Particularly on standing (postural hypotension), reported by some users at higher doses. More relevant in people taking blood pressure medications (additive hypotensive effect).

Serious adverse events at supplement CBD doses are rare. The primary safety concerns at supplement doses are drug interactions (below) rather than direct CBD toxicity.

CBD and Liver: What the Evidence Shows

At high doses — primarily the pharmaceutical doses studied in Epidiolex trials (10–20mg/kg/day, which for a 70kg adult is 700–1,400mg/day) — CBD produced liver enzyme elevations (ALT/AST) in a minority of patients, generally in combination with valproate (a hepatotoxic anticonvulsant that compounds the effect). At supplement doses (15–50mg/day), liver enzyme elevation has not been documented in controlled studies.

For healthy adults at supplement doses, CBD-related hepatotoxicity risk is very low. For individuals with pre-existing liver disease (cirrhosis, hepatitis, fatty liver disease), or those taking hepatotoxic medications, the threshold for CBD-induced liver stress may be lower — physician discussion is appropriate. Routine liver function monitoring is not recommended for healthy adults at supplement doses, but individuals on hepatotoxic medications who start CBD should be aware of the interaction.

CYP450 Drug Interactions: The Complete Table

CBD's most clinically significant safety concern at supplement doses is its inhibition of cytochrome P450 liver enzymes — particularly CYP3A4 and CYP2C9. These enzymes metabolize a large proportion of commonly prescribed medications. When CBD inhibits these enzymes, drug blood levels rise, potentially increasing both efficacy (wanted effect) and adverse effects (unwanted intensification or toxicity).

CBD inhibits: CYP3A4, CYP2C9 (most clinically significant); CYP2C19, CYP2D6 (to a lesser degree at supplement doses)

This table covers the most clinically relevant interactions; it is not exhaustive. Any prescription medication user should discuss CBD with their prescribing physician before starting.

Who Should Not Use CBD Without Physician Supervision

• Anyone on warfarin or other anticoagulants. CBD's CYP2C9 inhibition raises warfarin levels — a narrow therapeutic index drug where modest level increases create serious bleeding risk. This is the highest-priority drug interaction in CBD safety. Do not use CBD with warfarin without physician oversight and INR monitoring.
• Anyone on antiepileptic drugs. Bidirectional CYP450 interactions are complex and some may reduce seizure control. Ironically, CBD (as Epidiolex) is itself an approved antiepileptic — but supplement CBD used alongside other antiepileptics without physician guidance can produce unpredictable drug level changes.
• Anyone on immunosuppressants (transplant recipients, autoimmune disease patients on biologics). Narrow therapeutic index; toxicity from elevated levels is serious.
• Anyone pregnant or planning pregnancy. See dedicated section below.
• Anyone breastfeeding. See dedicated section below.
• Adolescents (under 18). See PureCraft's dedicated CBD for Teenagers guide.
• People with significant liver disease. Impaired liver function reduces CBD metabolism and lowers the threshold for potential hepatotoxicity; drug interactions are also more pronounced with impaired CYP450 function.
• People with Parkinson's disease on high-dose CBD. Some case reports suggest tremor worsening at high doses; lower doses appear safe and have shown benefit in some small studies.

CBD During Pregnancy

FDA Advisory: The FDA advises against using CBD, THC, or any cannabis-derived product during pregnancy. The developing fetal brain has ECS activity that is essential for neurodevelopment — cannabinoid system engagement during fetal development carries theoretical risk that is not characterized with sufficient human data to establish safety.

The precautionary principle applies unambiguously here: the potential consequences of disrupting fetal ECS neurodevelopment are serious, the human safety data is insufficient, and the benefit of CBD supplementation during pregnancy does not outweigh the theoretical risk. PureCraft CBD products are not recommended for use during pregnancy. Anyone using CBD who becomes pregnant should discontinue immediately and consult their obstetrician.

CBD During Breastfeeding

CBD is lipophilic and concentrates in breast milk. Infant exposure through breast milk is a meaningful concern — the same ECS neurodevelopment risks that apply in the fetal period apply to the neonatal period. FDA advises against CBD use during breastfeeding. PureCraft CBD products are not recommended for breastfeeding individuals. Consult your OB or pediatrician for any questions about cannabinoid exposure and infant safety.

CBD and Alcohol

CBD and alcohol both have CNS depressant effects — their combination may produce additive sedation, impaired motor control, and exaggerated hypotension at higher combined doses. At moderate CBD doses (15–30mg) and standard alcohol consumption, the interaction is mild. At high CBD doses, or when combined with heavy alcohol consumption, the additive CNS depression is meaningful. Regular alcohol users should be aware of this potentiation, and CBD should not be combined with alcohol in situations requiring alertness (driving, operating machinery).

Drug Testing and CBD

Pure CBD does not produce a positive drug test for THC — drug tests detect THC metabolites (specifically 11-nor-9-carboxy-THC), not CBD. However, broad-spectrum or full-spectrum CBD products contain variable amounts of THC, and cumulative THC exposure from these products can produce positive drug test results, particularly with daily high-dose use. This is the primary drug testing risk from CBD supplementation.

PureCraft CBD products are broad-spectrum with zero THC, independently verified by batch-specific COA. For individuals in safety-sensitive positions (DOT drug testing, military, professional athletics with USADA testing), see our dedicated CBD and Drug Testing guide.

Dosing Safety Thresholds

There is no established lethal dose of CBD in humans — toxicity studies suggest an extremely wide safety margin. The relevant safety thresholds for CBD at supplement doses are:

• 15–30mg/day (typical supplement dose): Well-tolerated by the vast majority of healthy adults. Side effects are mild and dose-dependent. Drug interaction risk is low-moderate depending on medications.
• 50–100mg/day (higher supplement dose): More commonly associated with fatigue and GI side effects; drug interaction risk is more clinically significant at these doses. Physician awareness warranted for anyone on CYP450-metabolized medications.
• Above 150mg/day (approaching pharmaceutical dosing territory): Side effects more frequent; liver enzyme monitoring warranted in long-term high-dose use; drug interactions more pronounced. This dose range should involve physician supervision.
• Epidiolex doses (10–20mg/kg/day): Clinical trial evidence — liver enzyme elevations occur in a subset, particularly with concurrent hepatotoxic medications. Not relevant to OTC supplement use.

Frequently Asked Questions

Is CBD safe to take every day?

For healthy adults not on CYP450-metabolized medications, daily CBD at supplement doses (15–30mg) has a well-characterized safety profile. The HPA recalibration and many other benefits of CBD require consistent daily use over 4–6 weeks to establish. Long-term safety data (years of daily use) is not as comprehensive as short-to-medium term data, but available evidence is reassuring. The caveat: "healthy adults not on relevant medications" excludes people on warfarin, antiepileptics, immunosuppressants, opioids, and several other drug categories where daily CBD use without physician oversight is not advisable.

Can CBD cause anxiety?

At typical supplement doses, CBD is anxiolytic — it reduces anxiety through 5-HT1A agonism and HPA recalibration. At very high doses, CBD may produce the opposite effect in some individuals — a paradoxical anxiogenic effect reported anecdotally. This is dose-dependent: if you experience increased anxiety with CBD, reducing the dose is the first intervention. The dose-response for CBD's anxiolytic effect is not strictly linear; more is not always better.

Does CBD interact with antidepressants?

Most common SSRIs (sertraline, escitalopram, fluoxetine) and SNRIs (venlafaxine, duloxetine) are metabolized partially through CYP2D6 and CYP2C19, enzymes that CBD inhibits to a lesser degree than CYP3A4 and CYP2C9. At supplement CBD doses, the interaction with most SSRIs is low-to-moderate and often clinically insignificant. However, physician awareness is appropriate — particularly for fluoxetine (a potent CYP2D6 inhibitor itself), where combined enzyme inhibition may have additive effects. Discuss CBD use with your psychiatrist or prescribing physician before starting.

Will CBD make me fail a drug test?

Pure CBD does not produce a positive drug test for THC. CBD products that contain THC (full-spectrum products) may produce a positive THC drug test with sufficient accumulated exposure. Zero-THC verified CBD (independently batch-tested with public COA) reduces this risk, though zero is not always absolute — "zero" in analytical chemistry means below the limit of detection, not an arithmetically absolute zero. For people in DOT testing, military, or professional sports testing environments, see our dedicated drug testing guide and consult your employer's policy.

Can I take CBD with ibuprofen or acetaminophen?

CBD's interaction with ibuprofen (CYP2C9) is low at supplement doses and generally considered clinically insignificant for occasional combined use. CBD's interaction with acetaminophen is not through CYP3A4 or CYP2C9 — acetaminophen is primarily metabolized through different pathways — though both have potential hepatic effects at high doses, making concurrent high-dose use of both worth monitoring. For occasional use at normal doses of both, the combination is generally considered low-risk in healthy adults.

The Bottom Line

CBD has a well-characterized safety profile at supplement doses for healthy adults not on medications affected by CYP450 inhibition. The common side effects — fatigue, dry mouth, GI upset at higher doses — are mild and dose-dependent. The serious safety concerns are concentrated in specific populations and drug interactions: warfarin (highest priority), antiepileptics, immunosuppressants, opioids, and pregnancy/breastfeeding. For these populations, CBD use without physician oversight is not appropriate. For healthy adults without these risk factors, daily CBD at 15–30mg/day has a favorable safety profile that is among the best-characterized of any commonly used wellness supplement. Zero-THC product verification (independently batch-tested COA) addresses the drug testing risk. Consistent dosing and timing maximize the benefit-to-side-effect ratio.

PureCraft Nano CBD Oil — 15–20mg daily. Zero THC, batch-tested COA publicly posted. Browse all products.

Medical Disclaimer | This article is a reference resource and does not substitute for personalized medical advice. CBD drug interactions and individual risk assessment require physician evaluation. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease.